Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Psychedelic/Assisted Therapies

Recent news which mentions Psychedelic/Assisted Therapies

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Orange Photonics: New High-Tech Testing For Psychedelic Products
Tags Psychedelics News Benzinga
From Benzinga
Small Pharma's Q2 2024 Financial Highlights Ahead Of Cybin Merger For Global DMT Business
Tickers CYBN DMT DMTTF
Tags financial results Benzinga M&A
From Benzinga
Congress Halts Hearing On Psychedelics & Veterans As House Speaker Drama Continues
Tags Psychedelics Reform Benzinga News
From Benzinga
New Survey Suggests Psilocybin Eases Psychological Distress From Childhood Trauma
Tags Psychological Distress Markets Cannabis
From Benzinga
EXCLUSIVE: Reason For Hope On Veteran Group Efforts, Comments To FDA & 2023 Expectations
Tags Psychedelics Benzinga FDA
From Benzinga
Lucy Scientific's Fiscal Year: Operating Expenses Rise As Accumulated Deficit Hits Over $44M
Tickers LSDI
Tags Psychedelic/Assisted Therapies Cannabis Benzinga
From Benzinga
Psyched: FDA Warning, DEA's Telehealth Extension, CA Gov's Veto, Congress On Kratom, M&As & More
Tickers ATAI CMPS CYBN DMTTF
Tags DRUG Cannabis SILO
From Benzinga
U.K.'s Prof. David Nutt Ranked World's Top Psychopharmacologist: More On His Contributions & Advocacy
Tickers AWKNF
Tags Drug Science AWKNF Psychedelic Science 2023 Conference
From Benzinga
Dem Presidential Candidate Calls For Universal Healthcare, Including Psychedelics Therapy
Tags Markets Marianne Williamson General
From Benzinga
Cybin And Small Pharma Shareholders Green Light Acquisition Resolution: Results & Expected Dates
Tickers CYBN DMTTF
Tags Psychedelic/Assisted Therapies CYBN DMTTF
From Benzinga
Pioneering Hope: Inside The Veteran's Organization Advancing Psychedelics Reform Policy
Tags military veterans Psychedelics Benzinga
From Benzinga
EXCLUSIVE: Understanding Real Estate For Psychedelic Treatments Boosted By Geospatial Mapping
Tickers AAPL IBM
Tags News IBM Tyler Zakovich
From Benzinga
EXCLUSIVE: The Need To Enhance Psychedelic Therapy Infrastructure, Data-Driven Solutions
Tags Management Psychedelic/Assisted Therapies Healing Realty Trust
From Benzinga
Maine's Portland Leads Drug Policy Reform, Decriminalizing Psychedelic Plants And Fungi
Tags Benzinga Psychedelics Market News
From Benzinga
Decoding Insurance Reimbursement For Psychedelic-Assisted Therapy With BrainFutures Guide
Tags Market News Psychedelic Therapy Practitioners BrainFutures
From Benzinga
Atai Life Sciences Completes Phase 1 Clinical Study Of Oral Film DMT Formulation
Tickers ATAI
Tags News DMT Clinical Trial Penny Stocks
From Benzinga
Cybin Completes Dosing In Phase 2 Study Of CYB003 For Major Depressive Disorder Treatment
Tickers CYBN
Tags CYBN major depressive disorder Management
From Benzinga
Steve Cohen Keeps Betting On Biopharma With Purchase Of 119M+ Bionomics Shares
Tickers BNOX CYBN MRK
Tags Financing Biopharma Steve Cohen
From Benzinga
Insider's Look At Psychedelics Industry On Risk Management, Gray Market & Cannabis Industry
Tags Interview Markets Health Insurance
From Benzinga
GH Research's Psychedelic Drug Candidate For Depression Meets FDA: Clinical Program On Hold
Tickers GHRS
Tags 5/MeO/DMT News GHRS
From Benzinga
Gov Newsom Green Lights Medical Psychedelics If Rescheduled And New Marijuana Testing Rules
Tags Markets Cannabis Cannabis Testing
From Benzinga
Psychedelic Therapy Providers: Risk Management Perspective From A Cannabis Insurance Specialist
Tags Benzinga Psychedelics Market News
From Benzinga
Argentina's Nacho Bottinelli On Psychedelics In Latin America: 'Brazil Opened A Giant Portal To Me'
Tags Argentina Psychedelics Psychedelics Benzinga
From Benzinga
Psyched: DMT & SSRIs For Depression, MDMA Training, Negative Responses To Psychedelics & More
Tickers ATAI CMPS CYBN DMTTF
Tags News ENVB PSIL
From Benzinga
Psychedelics Reform Update: Massachusetts, Pennsylvania, Maine, California, Michigan, Minnesota, Indiana
Tags News Psychedelics Benzinga
From Benzinga
PharmaTher Is 'One Step Closer To Being A Ketamine Leader' Due To FDA Acceptance
Tickers PHRRF
Tags Top Stories Guidance News
From Benzinga
Cybin And Fluence Partner To Support EMBARK Training For Phase 3 CYB003 Trial For Depression
Tickers CYBN
Tags Psychedelic Therapists Training Markets Global
From Benzinga
Depression Relief: Possible Therapy Boost With DMT & SSRIs, Per Small Pharma Clinical Results
Tickers CYBN DMTTF
Tags Penny Stocks Global Markets
From Benzinga
Defense Dept. Grants $1M To Yale & Transcend Therapeutics To Study PTSD Therapy
Tags Department of Defense Market News Yale University
From Benzinga
Psyched: Steve Cohen Goes Big On Cybin, Fed Intervention On Psilocybin, Ketamine Insurance And More
Tickers ATAI CMPS CYBN DMTTF
Tags LSDI HUGE Penny Stocks
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.